498 related articles for article (PubMed ID: 28296232)
21. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous Target-Mediated Drug Disposition Model for Two Small-Molecule Compounds Competing for Their Pharmacological Target: Soluble Epoxide Hydrolase.
Wu N; Hammock BD; Lee KSS; An G
J Pharmacol Exp Ther; 2020 Jul; 374(1):223-232. PubMed ID: 32238455
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of soluble epoxide hydrolase reduces portal pressure by protecting mesenteric artery myogenic responses in cirrhotic rats.
Huang Y; Qin J; Sun D; Jiang H; Zheng L; He Y; Gui L; Qian B; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():17-24. PubMed ID: 28473204
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.
Sodhi RK; Singh M; Singh N; Jaggi AS
Arch Pharm Res; 2009 Jul; 32(7):1037-43. PubMed ID: 19641885
[TBL] [Abstract][Full Text] [Related]
26. Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress.
Batchu SN; Lee SB; Samokhvalov V; Chaudhary KR; El-Sikhry H; Weldon SM; Seubert JM
Can J Physiol Pharmacol; 2012 Jun; 90(6):811-23. PubMed ID: 22624559
[TBL] [Abstract][Full Text] [Related]
27. Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation.
Darwesh AM; Keshavarz-Bahaghighat H; Jamieson KL; Seubert JM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31319469
[TBL] [Abstract][Full Text] [Related]
28. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
Katary MM; Pye C; Elmarakby AA
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333
[TBL] [Abstract][Full Text] [Related]
29. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
[TBL] [Abstract][Full Text] [Related]
30. Targeting IRE1α-JNK-c-Jun/AP-1-sEH Signaling Pathway Improves Myocardial and Coronary Endothelial Function Following Global Myocardial Ischemia/Reperfusion.
Xue HM; Sun WT; Chen HX; He GW; Yang Q
Int J Med Sci; 2022; 19(9):1460-1472. PubMed ID: 36035373
[No Abstract] [Full Text] [Related]
31. 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats.
Bukhari IA; Mohamed OY; Mahmood A; Alfadda AA; Almotrefi AA
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(10):3835-3847. PubMed ID: 34109592
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.
Zhang LN; Vincelette J; Chen D; Gless RD; Anandan SK; Rubanyi GM; Webb HK; MacIntyre DE; Wang YX
Eur J Pharmacol; 2011 Mar; 654(1):68-74. PubMed ID: 21187082
[TBL] [Abstract][Full Text] [Related]
33. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
Bukhari IA; Alorainey BI; Al-Motrefi AA; Mahmoud A; Campbell WB; Hammock BD
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8143-8150. PubMed ID: 32767352
[TBL] [Abstract][Full Text] [Related]
34. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
[TBL] [Abstract][Full Text] [Related]
35. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
36. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.
Tu R; Armstrong J; Lee KSS; Hammock BD; Sapirstein A; Koehler RC
Sci Rep; 2018 Mar; 8(1):5279. PubMed ID: 29588470
[TBL] [Abstract][Full Text] [Related]
37. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
38. Soluble epoxide hydrolase inhibitors and heart failure.
Qiu H; Li N; Liu JY; Harris TR; Hammock BD; Chiamvimonvat N
Cardiovasc Ther; 2011 Apr; 29(2):99-111. PubMed ID: 20433684
[TBL] [Abstract][Full Text] [Related]
39. Soluble Epoxide Hydrolase Inhibition by
Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
[TBL] [Abstract][Full Text] [Related]
40. Effects of gallic acid on hemodynamic parameters and infarct size after ischemia-reperfusion in isolated rat hearts with alloxan-induced diabetes.
Ramezani-Aliakbari F; Badavi M; Dianat M; Mard SA; Ahangarpour A
Biomed Pharmacother; 2017 Dec; 96():612-618. PubMed ID: 29035826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
